테네시의 비만 임상 시험
비만 관련 연구 38개가 테네시 내 여러 지역에서 참여자를 모집하고 있습니다.
테네시의 도시
공식 연구 텍스트(영어)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Holston Medical Group - Bristol /ID# 282045, Bristol
- New Phase Research & Development /ID# 282131, Knoxville
- Summit Medical Group- Halls Family Physicians /ID# 282435, Knoxville
- 외 1개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07752979AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- M3 Wake Research Chattanooga, Chattanooga
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- LifeDoc Health, Memphis
피험자 모집 중3상
8세 ~ 18세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07253285Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- AMR Clinical, Nashville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07837973Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Center Of The Midsouth, Cordova
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Vanderbilt Health One Hundred Oaks, Nashville
피험자 모집 중3상
6세 ~ 17세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Center Of The Midsouth, Cordova
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937086A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Franklin
- Research Site, Jackson
- Research Site, Knoxville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Stern Cardiovascular Foundation Inc, Germantown
- Accellacare of Knoxville, Knoxville
- Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell
- 외 1개
피험자 모집 중3상
45세 ~ 99세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- AMR Clinical, Nashville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07321886A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Quality Medical Research, Nashville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07589608Transition to Ambulatory Bariatric Surgery (TABS) Trial
- Vanderbilt University Medical Center, Nashville
피험자 모집 중
25세 ~ 55세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07011628A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Memphis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Memphis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Apex Research Foundation, LLC, Jackson
- The Jackson Clinic PA, Jackson
- Parkway Cardiology Associates, Oak Ridge
- 외 2개
피험자 모집 중3상
18세 ~ 99세 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Innovative Clinical Research, Clarksville
- Clinical Research Associates, Nashville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Nashville
피험자 모집 중3상건강한 지원자 환영
18세 ~ 79세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Quality Medical Research, Nashville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06143956A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- DelRicht Research - Thompson's Station, Smyrna
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailea Clinical Site, Memphis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- New Phase Research and Development, Knoxville
피험자 모집 중3상
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07684235Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Chattanooga
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07284875The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
- Vanderbilt University Medical Center, Nashville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT05972564A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Kingsport
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07784725A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Balad Hlth Sys-Welmont CardCVA, Greeneville
- The Jackson Clinic, PA, Jackson
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07567001Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Knoxville
피험자 모집 중3상
18세 ~ 79세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07654361Atomoxetine in Melanocortin Obesity Syndrome
- Vanderbilt University Medical Center, Nashville
피험자 모집 중2상
6세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06899178A Study to Improve Skeletal Muscle in Veterans With HIV
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
피험자 모집 중
20세 ~ 80세 · 남성 · 2026. 6. 26. 업데이트됨 · NCT06845046Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Holston Medical Group_Bristol, Bristol
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 25. 업데이트됨 · NCT07607587Daily Eating Patterns for Total Health Study
- Healthy Eating and Activity Laboratory, Knoxville
피험자 모집 중
25세 ~ 60세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT06455995A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
- MBX Biosciences Investigational Site, Knoxville
피험자 모집 중1상
18세 ~ 65세 · 모든 성별 · 2026. 6. 9. 업데이트됨 · NCT07142707EBT Fruit and Vegetable Prescription
- Cherokee Health Systems, Dameron Avenue Pedatrics, Knoxville
피험자 모집 중건강한 지원자 환영
4세 ~ 10세 · 모든 성별 · 2026. 6. 9. 업데이트됨 · NCT05028205Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT07228741Metabolic Effects of Angiotensin-(1-7)
- Vanderbilt University Medical Center, Nashville
피험자 모집 중1상
18세 ~ 60세 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT02646475Sympathetic Mechanisms in Obesity-Crossover Design
- Vanderbilt University Medical Center, Nashville
피험자 모집 중1/2상
18세 ~ 65세 · 모든 성별 · 2026. 2. 27. 업데이트됨 · NCT05312892A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
- Vanderbilt University Medical Center (Part C only), Nashville
피험자 모집 중1/2상건강한 지원자 환영
12세 ~ 65세 · 모든 성별 · 2025. 12. 22. 업데이트됨 · NCT06239116Tirzepatide in PWS, HO and GNSO
- Vanderbilt University Medical Center, Nashville
피험자 모집 중4상
18세 ~ 26세 · 모든 성별 · 2025. 9. 16. 업데이트됨 · NCT06901245Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
- University of Tennessee Medical Center, Knoxville
피험자 모집 중관찰 연구
18세 ~ 45세 · 여성 · 2025. 9. 10. 업데이트됨 · NCT06802861ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.